Lesson 15
Adrenal Gland Overview
- Two adrenal glands located atop each kidney (suprarenal glands).
- Divided into two areas:
- Medulla: Secretes catecholamines.
- Cortex: Secretes glucocorticoids, mineralocorticoids, and androgens.
Autonomic Innervation
- Innervated by preganglionic sympathetic nerves (T5 - T9), no postganglionic nerves.
- Preganglionic sympathetic B fibers release acetylcholine (ACh) onto chromaffin cells.
- Stimulation of chromaffin cells leads to release of epinephrine (Epi) and norepinephrine (NE) directly into circulation.
Catecholamine Release
- Epi secretion at rest: 0.2 mcg/kg/min (80% total output).
- NE secretion at rest: 0.05 mcg/kg/min (20% total output).
- Catecholamines remain in bloodstream 5-10 times longer than in synaptic cleft.
Pheochromocytoma
- Catecholamine-secreting tumor from adrenal gland or extra chromaffin tissue.
- Classic symptoms: headache, diaphoresis, tachycardia.
- Diagnosis: Elevated urine VMA levels.
- Associated with MEN syndrome types 2A and 2B.
Preoperative Pharmacological Considerations
- Alpha blockade necessary before beta blockade (A before B).
- Common alpha antagonists:
- Non-selective: phenoxybenzamine, phentolamine.
- Alpha-1 selective: doxazosin, prazosin.
- Risks of beta blockade first: heart failure, reduced inotropy, increased systemic vascular resistance (SVR).
Anesthetic Considerations
- Pre-ligation: anticipate hypertension, tachycardia, hyperglycemia.
- Treatments: sodium nitroprusside, nitroglycerin, clevidipine, nicardipine, deepened anesthesia, short-acting beta-blockers.
- Post-ligation: anticipate hypotension, hypoglycemia due to downregulation.
- Treatments: phenylephrine, NE, vasopressin, IV fluids, consider steroid supplementation if both adrenal glands manipulated.
Drugs to Avoid
- Avoid if alternatives are available:
- Histamine-releasing agents (e.g., succinylcholine, morphine).
- Indirect-acting sympathomimetics (e.g., ephedrine).
- SNS activators (e.g., desflurane, ketamine).